Mesoblast Limited (MESO)
(Delayed Data from NSDQ)
$15.17 USD
-0.09 (-0.59%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $15.09 -0.08 (-0.53%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Mesoblast Limited's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MESO 15.17 -0.09(-0.59%)
Will MESO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MESO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MESO
Mesoblast Limited (MESO) Is Up 40.59% in One Week: What You Should Know
Mesoblast Limited (MESO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
MESO: What are Zacks experts saying now?
Zacks Private Portfolio Services
MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug
What Awaits These 4 Biotech Stocks That More Than Doubled in 2024
MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease
Other News for MESO
12 Health Care Stocks Moving In Friday's Intraday Session
Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday
Mesoblast (MESO) Downgraded by Jefferies to Hold | MESO Stock News
12 Health Care Stocks Moving In Friday's Pre-Market Session
This Elevance Health Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday